Cardiol Therapeutics | WebDisclosure

Basculer en Français

11223	Companies
248902	Keywords
176712	Articles
134722	Press releases

Home
Companies
Cardiol Therapeutics

BRIEF

published on 04/17/2026 at 15:36, 6 months 6 days ago

Research Update on Cardiol Therapeutics by First Berlin Equity Research

Clinical Trials Research Update Price Target Cardiol Therapeutics Capital Raise
PRESS RELEASE

published on 04/17/2026 at 15:31, 6 months 6 days ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates BUY recommendation for Cardiol Therapeutics Inc to USD 7.50 target price due to recent corporate updates and pipeline progress, including MAVERIC trial advancements

Cardiol Therapeutics Inc First Berlin Equity Research Buy Recommendation Pipeline Progress MAVERIC Trial
BRIEF

published on 12/17/2025 at 14:43, 10 months 6 days ago

First Berlin Equity Research met à jour sa recommandation sur Cardiol Therapeutics, passant à « Acheter » avec un objectif de cours abaissé.

Recommandation D'achat Ajustement Du Prix Cible Thérapeutique Cardiaque Étude ARCHER De Phase II Myocardite
BRIEF

published on 12/17/2025 at 14:43, 10 months 6 days ago

First Berlin Equity Research Updates Cardiol Therapeutics to "Buy" with a Lowered Target Price

Buy Recommendation Target Price Adjustment Cardiol Therapeutics Phase II ARCHER Study Myocarditis
PRESS RELEASE

published on 12/17/2025 at 14:38, 10 months 6 days ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates BUY recommendation for Cardiol Therapeutics Inc., lowering price target to USD 7.80 based on positive Phase II ARCHER data on CardiolRx for acute myocarditis

First Berlin Equity Research Buy Recommendation Acute Myocarditis Cardiol Therapeutics Inc. Phase II ARCHER Data
BRIEF

published on 10/23/2025 at 12:56, 1 year ago

Cardiol Therapeutics obtient un financement avec un placement privé de 11,4 millions de dollars

Placement Privé Essais Cliniques Cardiol Therapeutics Perspectives Financières Traitement De L'insuffisance Cardiaque
BRIEF

published on 10/23/2025 at 12:56, 1 year ago

Cardiol Therapeutics Secures Funding with USD 11.4 Million Private Placement

Private Placement Clinical Trials Financial Outlook Cardiol Therapeutics Heart-Failure Therapy
PRESS RELEASE

published on 10/23/2025 at 12:51, 1 year ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates Cardiol Therapeutics Inc with a BUY rating and USD 8.50 price target. The private placement secures funds for pivotal trials and new product development

Private Placement Cardiol Therapeutics Inc First Berlin Equity Research BUY Rating USD 8.50 Price Target
BRIEF

published on 08/12/2025 at 13:36, 1 year 2 months ago

Cardiol Therapeutics : résultats de l'essai de phase II et perspectives boursières positives

Cardiol Therapeutics Acheter Une Note CardiolRx Essai ARCHER De Phase II Myocardite Aiguë
BRIEF

published on 08/12/2025 at 13:36, 1 year 2 months ago

Cardiol Therapeutics: Phase II Trial Results and Positive Stock Outlook

BUY Rating Cardiol Therapeutics CardiolRx Phase II ARCHER Trial Acute Myocarditis

Accesswire

Published on 10/24/2026 at 00:25, 5 hours 22 minutes ago

Caldwell Announces Sale of IQTalent
Published on 10/24/2026 at 00:04, 5 hours 43 minutes ago

Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters
Published on 10/23/2026 at 23:30, 6 hours 17 minutes ago

Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita
Published on 10/23/2026 at 21:55, 7 hours 52 minutes ago

Apex Closes Offering and Completes NASDAQ Listing
Published on 10/23/2026 at 16:00, 13 hours 47 minutes ago

Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award

View all ACCESSWIRE

EQS Group

Published on 10/23/2026 at 18:55, 10 hours 52 minutes ago

Qatar's Years of Culture Initiative Announces Partner Countries Through 2030
Published on 10/23/2026 at 18:00, 11 hours 47 minutes ago

BIOSYNEX SA: CHEMBIO DIAGNOSTIC SYSTEMS AWARDED $5.7 MILLION TO ADVANCE DPP® BIOTHREAT PANEL
Published on 10/23/2026 at 18:00, 11 hours 47 minutes ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.09.26
Published on 10/23/2026 at 17:55, 11 hours 52 minutes ago

Tout entendre, sans rien téléverser : VoxNexus lance la première intelligence artificielle (IA) vocale pour Android à écoute continue, à faible consommation et entièrement embarquée
Published on 10/23/2026 at 17:55, 11 hours 52 minutes ago

Hears Everything, Uploads Nothing: VoxNexus Launches Android's First Low-Power On-Device Always-On Voice Artificial Intelligence (AI)

Les Echos

Published on 10/23/2026 at 20:33, 9 hours 14 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 19 au 23 octobre 2026
Published on 10/23/2026 at 20:33, 9 hours 14 minutes ago

Disclosure of transactions in own shares from October 19 to October 23, 2026
Published on 10/23/2026 at 17:45, 12 hours 2 minutes ago

Imerys-10-2026-communique-capital-droits-de-vote-au-30-septembre-2026
Published on 10/23/2026 at 17:45, 12 hours 2 minutes ago

Imerys-10-2026-information-share-capital-and-voting-rights-as-of-30-September-2026
Published on 10/23/2026 at 17:45, 12 hours 2 minutes ago

Klarsen : Comptes semestriels 2026

View all LES ECHOS COMFI WIRE